HCA logo

HCA Healthcare Inc. (HCA)

$376.50

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on HCA

Market cap

$83.52B

EPS

29.03

P/E ratio

14.9

Price to sales

1.26

Dividend yield

0.829%

Beta

1.122587

Price on HCA

Previous close

$371.87

Today's open

$370.09

Day's range

$370 - $378.26

52 week range

$330 - $556.52

Profile about HCA

CEO

Samuel N. Hazen

Employees

320000

Headquarters

Nashville, TN

Exchange

New York Stock Exchange

Shares outstanding

221839800

Issue type

Common Stock

HCA industries and sectors

Healthcare

Healthcare Providers & Services

News on HCA

HCA Healthcare Reports Second Quarter 2026 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2026. The Company's financial and operating results, as well as its updated guidance and key assumptions, are consistent with its July 14, 2026 second quarter preview. Key second quarter metrics (all percentage changes compare 2Q 2026 to 2Q 2025 unless otherwise noted): Revenues increased 8.7 percent to $20.230 billion Net income attributable.

news source

Business Wire • 3 hours ago

news preview

HCA Healthcare (HCA) Q2 Earnings Surpass Estimates

HCA Healthcare (HCA) came out with quarterly earnings of $7.59 per share, beating the Zacks Consensus Estimate of $7.57 per share. This compares to earnings of $6.84 per share a year ago.

news source

Zacks Investment Research • an hour ago

news preview

American Express, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday

With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:

news source

Benzinga • 9 hours ago

news preview

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA

NEW YORK, July 23, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

news source

PRNewsWire • Jul 23, 2026

news preview

HCA Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm

RADNOR, Pa., July 23, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by HCA Healthcare, Inc. (NYSE: HCA) on behalf of investors who purchased or acquired HCA Healthcare, Inc. securities and experienced significant financial losses.

news source

PRNewsWire • 19 hours ago

news preview

HCA Healthcare, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, July 22, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises HCA Healthcare, Inc., (“HCA" or the "Company") (NYSE: HCA) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.  Investors are encouraged to contact attorney Lesley F.

news source

GlobeNewsWire • Jul 22, 2026

news preview

HCA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating HCA Healthcare, Inc. on Behalf of HCA Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In HCA To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in  HCA and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648.

news source

GlobeNewsWire • Jul 21, 2026

news preview

NYSE: HCA Investigation: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm

RADNOR, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by HCA Healthcare, Inc. (NYSE: HCA) on behalf of investors who purchased or acquired HCA Healthcare, Inc. securities and experienced significant financial losses.

news source

GlobeNewsWire • Jul 21, 2026

news preview

HCA INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

news source

GlobeNewsWire • Jul 21, 2026

news preview

NYSE: HCA Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by HCA Healthcare, Inc. (NYSE: HCA) on behalf of investors who purchased or acquired HCA Healthcare, Inc. securities and experienced significant financial losses.HCA Announces Disappointing Financial ResultsOn July 14, 2026, HCA issued a press release reporting its preliminary financial an.

news source

Business Wire • Jul 20, 2026

news preview

¹ Disclosures

Get started with M1

Invest in HCA Healthcare Inc.

Open an M1 investment account to buy and sell HCA Healthcare Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in HCA on M1